SCHEMBL19034570

SCHEMBL19034570

CCCOC(=O)CCCN1CCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.55
▸ L3MBTL1 Q9Y468 1/20 0.55
▸ DGKA P23743 1/20 0.47
▸ MAPT P10636 5/20 0.47
▸ MAPK1 P28482 3/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ THRB P10828 5/20 0.43
▸ LMNA P02545 2/20 0.43
▸ KCNH2 Q12809 2/20 0.43
▸ HRH3 Q9Y5N1 2/20 0.43
▸ HRH2 P25021 2/20 0.43
▸ HRH1 P35367 2/20 0.43
▸ CHRM2 P08172 1/20 0.43
▸ CHRM4 P08173 1/20 0.43
▸ CHRM5 P08912 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ ADRA2C P18825 1/20 0.43
▸ DRD4 P21917 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19034571 0.92 DGKA (0.50) ALDH1A1L3MBTL1DGKAMAPTMAPK1
SCHEMBL12879889 0.88 PAOX (0.49) ALDH1A1L3MBTL1DGKAMAPTMAPK1
SCHEMBL31661129 0.87 ALDH1A1 (0.46) ALDH1A1L3MBTL1DGKAMAPTMAPK1
SCHEMBL10084759 0.86 CYP1A2 (0.50) ALDH1A1L3MBTL1MAPK1SMN1; SMN2CYP1A2
SCHEMBL31661139 0.85 ALDH1A1 (0.45) ALDH1A1L3MBTL1DGKAMAPTMAPK1
SCHEMBL7509641 0.85 ALDH1A1 (0.45) ALDH1A1L3MBTL1DGKAMAPTMAPK1
SCHEMBL31661130 0.83 ALDH1A1 (0.43) ALDH1A1L3MBTL1DGKAMAPTMAPK1
SCHEMBL1855324 0.82 CYP1A2 (0.53) ALDH1A1L3MBTL1MAPTMAPK1SMN1; SMN2
SCHEMBL674334 0.82 ALDH1A1 (0.46) ALDH1A1L3MBTL1DGKAMAPTMAPK1
SCHEMBL419258 0.82 ALDH1A1 (0.46) ALDH1A1L3MBTL1DGKAMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9687448-B2 Nucleic acid lipid particle formulations ALNYLAM PHARMACEUTICALS, INC. (US) 2017-06-27 — — US disclosed
Send feedback